| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |